<DOC>
	<DOCNO>NCT00952627</DOCNO>
	<brief_summary>The purpose study determine whether Pycnogenol , natural pine bark extract , effective modify age-dependent process cardiac fibrosis diastolic function age hypertensive subject .</brief_summary>
	<brief_title>Effects Pycnogenol Cardiac Fibrosis Diastolic Dysfunction Aged Hypertensive Subjects</brief_title>
	<detailed_description>Diastolic heart failure without leave ventricular systolic dysfunction comprise 30 % 50 % heart failure clinical practice , hypertensive heart disease major cause type heart failure . The complication myocardial fibrosis avoid hypertensive heart disease , increase ventricular stiffness cause myocardial fibrosis lead development diastolic dysfunction heart . Diastolic dysfunction patient prolonged hypertension often associate myocardial fibrosis addition muscular hypertrophy final feature hypertensive heart disease . The high risk develop maladaptive cardiac remodel hypertension , failure pharmacological treatment limit even reverse progressive stiffening myocardium , lead study effect Pycnogenol , bioflavonoid-rich pine bark extract , pleiotropic action cardiovascular system . Pycnogenol prevent adverse hypertension-induced myocardial remodeling mouse , modulation gene expression activity enzyme matrix metalloproteinases tissue inhibitor , affect myocardial collagen degradation rate . Despite mount evidence suggest anti-remodeling effect Pycnogenol animal model , clinical efficacy Pycnogenol hypertension-induced diastolic dysfunction unreported . This lead central hypothesis Pycnogenol reverse hypertension-induced cardiac fibrosis diastolic dysfunction hypertensive patient . Therefore clinical investigation , investigate effect Pycnogenol modify hypertension-induced cardiac fibrosis ( measure serum marker myocardial fibrosis collagen turnover ) diastolic dysfunction ( transthoracic echocardiogram ) . We expect improve diastolic function ameliorate myocardial fibrosis nutritional supplement Pycnogenol , modulation MMPs TIMPs enzyme activity .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pycnogenols</mesh_term>
	<criteria>The subject consist ambulatory male female , 5075 year age , race , diagnose hypertension ( diagnosis make 6 month ) , echocardiographic evidence grade I II diastolic dysfunction . There need standardization hypertension treatment , select patient diastolic dysfunction treatment . Unstable angina myocardial infarction past 3 month . Biochemical evidence renal hepatic failure . Severe anemia : define hemoglobin level le 7 g/dL . Current cancer major illness associate heart . Bleeding disorder . Taking anticoagulant include low dose aspirin . Diabetes . Known allergy Pycnogenol . Being pregnant breastfeeding . Systolic blood pressure 180 mmHg less 100 mmHg , Diastolic blood pressure 110 mmHg less 50 mmHg . Current smoking . Having breast implant . Taking follow : birth control product , Diethylstilbestrol , Ephedra , ephedrine , pseudoephedrine ( except use prescription product ) , hormone replacement product , Isotretinoin , product contain mercury , Phentermine combination fenfluramine ( include limit Pondimin ) dexfenfluramine ( Redux ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Cardiac fibrosis</keyword>
	<keyword>Diastolic dysfunction</keyword>
	<keyword>Hypertension</keyword>
</DOC>